ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

SUPN Supernus Pharmaceuticals Inc

26,73
0,74 (2,85%)
Última atualização: 15:48:05
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Supernus Pharmaceuticals Inc SUPN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,74 2,85% 26,73 15:48:05
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
25,98 25,86 26,88 25,99
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/05/202417:25GLOBESupernus Pharmaceuticals to Participate in the Jefferies..
23/05/202417:05GLOBESupernus Announces Promising Interim Data from Ongoing..
09/05/202417:05GLOBESupernus Pharmaceuticals to Host Webcast to Review Interim..
08/05/202417:05GLOBESupernus Announces First Quarter 2024 Financial Results
07/05/202411:00PRNUSM8 Pharmaceuticals, an Acino company, signs an exclusive..
01/05/202409:00GLOBEBusy Philipps Shines Spotlight on ADHD in Women and Shares..
24/04/202417:05GLOBESupernus Pharmaceuticals to Announce First Quarter 2024..
08/04/202409:00GLOBESupernus Provides Regulatory Update for SPN-830
06/03/202418:30GLOBESupernus to Participate in Two Upcoming Investor Conferences
28/02/202418:30GLOBESupernus to Participate in the TD Cowen 44th Annual..
27/02/202418:05GLOBESupernus Announces Fourth Quarter and Full Year 2023..
13/02/202418:05GLOBESupernus Pharmaceuticals to Announce Fourth Quarter and Full..
05/02/202410:30GLOBESupernus Wins Infringement and Validity Case on Trokendi XR®..
19/12/202309:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
12/12/202307:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
08/11/202318:05GLOBESupernus Announces Third Quarter 2023 Financial Results
07/11/202318:30GLOBESupernus to Participate in the Jefferies London Healthcare..
02/11/202308:00GLOBESupernus Announces SPN-830 Apomorphine Infusion Device NDA..
25/10/202317:15GLOBESupernus Pharmaceuticals to Announce Third Quarter 2023..
16/10/202318:34GLOBEJay Glazer Teams Up with Supernus Pharmaceuticals to Raise..
09/10/202318:45DJNSupernus Resubmits NDA to FDA for Apomorphine Infusion..
09/10/202317:45GLOBESupernus Resubmits NDA for SPN-830 Apomorphine Infusion..
27/09/202317:15GLOBESupernus Pharmaceuticals Announces Webcast of R&D Day to be..
09/09/202321:00GLOBESupernus Announces New Qelbree® Data Showing Improvement in..
31/08/202318:30GLOBESupernus to Participate in the Wells Fargo Healthcare..
21/08/202310:00GLOBEBethany L. Sensenig Joins Supernus’ Board of Directors
08/08/202317:17GLOBESupernus Announces Second Quarter 2023 Financial Results
24/07/202317:05GLOBESupernus Pharmaceuticals to Announce Second Quarter 2023..

Seu Histórico Recente

Delayed Upgrade Clock